Kevin Koch Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Kevin Koch MGEN stock SEC Form 4 insiders trading

Kevin has made over 8 trades of the Miragen Therapeutics Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Kevin exercised 22,286 units of MGEN stock worth $83,573 on 24 July 2013.

The largest trade Kevin's ever made was exercising 35,119 units of Miragen Therapeutics Inc stock on 12 February 2008 worth over $8,429. On average, Kevin trades about 6,526 units every 118 days since 2003. As of 24 July 2013 Kevin still owns at least 797,240 units of Miragen Therapeutics Inc stock.

You can see the complete history of Kevin Koch stock trades at the bottom of the page.

What's Kevin Koch's mailing address?

Kevin's mailing address filed with the SEC is C/O MIRAGEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER, CO, 80301.

Insiders trading at Miragen Therapeutics Inc

Over the last 8 years, insiders at Miragen Therapeutics Inc have traded over $636,110 worth of Miragen Therapeutics Inc stock and bought 1,041,411 units worth $5,368,137 . The most active insiders traders include Bennett S Lebow, Bruce Booth, and Paul D Rubin. On average, Miragen Therapeutics Inc executives and independent directors trade stock every 91 days with the average trade being worth of $2,345,685. The most recent stock trade was executed by Global Master Fund Lp Logos on 9 November 2020, trading 476,667 units of MGEN stock currently worth $2,268,935.

What does Miragen Therapeutics Inc do?

Miragen Therapeutics Inc executives and stock owners

Miragen Therapeutics Inc executives and other stock owners filed with the SEC include:

• Diana Escolar,
  Chief Medical Officer
• Jason Leverone,
  Principal Financial Officer, Principal Accounting Officer, Treasurer, Secretary
• Jeffrey Hatfield,
  Independent Chairman of the Board
• Joseph Turner,
  Independent Director
• Arlene Morris,
  Independent Director
• Christopher Bowden,
  Independent Director
• Tomas Kiselak,
  Director
• Peter Harwin,
  Director
• Lee Rauch,
  Chief Executive Officer, Director
• Jonathan Violin,
  President, Chief Operating Officer
• Bruce Booth,
  Director
• Kyle Lefkoff,
  Director
• Paul D Rubin,
  EVP, Research & Development
• Adam Scott Levy,
  Chief Business Officer
• Thomas E. Hughes,
  Director
• Bennett S Lebow,
  Director
• Global Master Fund Lp Logos,
  10% owner
• John W Creecy,
  Director
• Kevin Koch,
  Director
• Funds Management Llc Fairmo...,
  
• William Stuart Marshall,